Loading
Omada Health, Inc. Stock: price and insider trades · United States
Insider Decl.
208
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€10M
58 ops. · all time
Who traded when
BuySaleSean P. Duffy25 sales
Steven L. Cook19 sales
Craig Gracey8 sales
Wei-Li Shao6 sales
Analyst consensus: bullish or bearish?
Analysts rate Omada Health, Inc. Buy (bullish), based on 12 analysts. Average price target: US$28.42.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,453 of 26,280 companies
40.8
score / 100
Value36
Quality45
FCF yld1.0%
Earn yld-1.1%
EV/EBITDA·
ROE1.8%
Gross mgn66%
Net mgn-4.9%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$19.66
Analyst consensus
12 analystsBuy
US$22.00Target US$28.42(+45%)US$35.00
Income statement
RevenueUS$260.2M
Gross profitUS$170.9M66% margin
EBITDA-US$4.8M-2% margin
Net income-US$12.8M1.4% margin
Valuation
PER (trailing)81.9x
PER (forward)35.4x
P/Book4.7x
Balance sheet & cash
Market capUS$1.2B
Free Cash FlowUS$12.4M
Profitability & ownership
ROE1.8%
ROA-0.1%
% insiders2.1%
% institutions88.2%
Last declaration on 7 October 2026
Declarations208 total
694 shares0Common StockSEC:0001610717-26-000431:0
751 shares0Common StockSEC:0001610717-26-000429:0
549 shares0Common StockSEC:0001610717-26-000430:0
1,214 shares0Common StockSEC:0001610717-26-000428:0
12,944 shares@ US$5.820.0063% mcap1.5% of flowCommon StockSEC:0001610717-26-000426:0
4,314 shares@ US$8.280.0030% mcap0.7% of flowCommon StockSEC:0001610717-26-000426:1
12,944 shares@ US$20.60820.022% mcap5.2% of flowCommon StockSEC:0001610717-26-000426:2
4,314 shares@ US$20.900.0075% mcap1.8% of flowCommon StockSEC:0001610717-26-000426:3
17,258 shares@ US$15.60810.022% mcap23.5% of flowCommonSEC144:0001950047-26-009934
6,200 shares@ US$21.79520.012% mcap2.7% of flowCommon StockSEC:0001610717-26-000416:0
600 shares@ US$22.51610.0012% mcap0.3% of flowCommon StockSEC:0001610717-26-000416:1
13,560 shares@ US$21.79710.026% mcap5.4% of flowCommon StockSEC:0001610717-26-000417:0
1,400 shares@ US$22.59160.0028% mcap0.6% of flowCommon StockSEC:0001610717-26-000417:1
3,636 shares@ US$21.78030.0069% mcap8.1% of flowCommon StockSEC:0001610717-26-000415:0
400 shares@ US$22.53250.0008% mcap0.9% of flowCommon StockSEC:0001610717-26-000415:1
644 shares@ US$21.73160.0012% mcap3.0% of flowCommon StockSEC:0001610717-26-000413:0
6,800 shares@ US$21.500.013% mcap8.1% of flowCommonSEC144:0001950047-26-009315
14,960 shares@ US$21.500.028% mcap12.8% of flowCommonSEC144:0001950047-26-009297
4,036 shares@ US$21.500.0076% mcap22.6% of flowCommonSEC144:0001950047-26-009314
644 shares@ US$22.180.0012% mcap3.9% of flowCommonSEC144:0001950047-26-009246
2,010 shares@ US$22.770.0040% mcap0.9% of flowCommon StockSEC:0001610717-26-000407:0
4,422 shares@ US$22.770.0088% mcap1.0% of flowCommon StockSEC:0001610717-26-000406:0
1,843 shares@ US$22.770.0037% mcap4.3% of flowCommon StockSEC:0001610717-26-000408:0
9,418 shares@ US$25.01670.018% mcap24.3% of flowCommon StockSEC:0001610717-26-000404:0
6,180 shares@ US$22.840.011% mcap14.5% of flowCommon StockSEC:0001610717-26-000400:0
25 of 208 declarations
About Omada Health, Inc.
Omada Health, Inc. has filed no open-market purchase since it entered the filings: 208 filings from 17 filers between June 5, 2025 and October 5, 2026, 40 of them in 2025 and 168 in 2026. The 58 sales total EUR 10,482,397, with a median of EUR 82,439. The two largest are by Sean P. Duffy, Chief Executive Officer, who reported EUR 1,848,661 and EUR 1,244,813 on January 12, 2026. Steven L. Cook, Chief Financial Officer, sold EUR 577,774 on June 26, 2026.
The record includes 57 grants, 42 option exercises and 51 filings of another kind. Sean P. Duffy is the most active filer, with 51 filings, 25 of them sales; Steven L. Cook has 45 (19 sales), Craig Gracey, Chief Accounting Officer, 17, Wei-Li Shao, President, 13 and Jonathan D. Root, Director, 12, with no market trade.
Read moreShow less
Over the last twelve months: 178 filings, 58 of them sales. The company, listed on Nasdaq and valued at USD 1,105,573,632, publishes its filings a median of 2 days after the trade.
